Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novocure Ltd NVCR

Healthcare Medical Devices
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and... see more

Recent & Breaking News (NDAQ:NVCR)

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 14, 2023

NVCR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 18, 2023 in the Class Action Filed on Behalf of NovoCure Limited Shareholders

PR Newswire July 14, 2023

NVCR SHAREHOLDER ALERT: Jakubowitz Law Reminds NovoCure Shareholders of a Lead Plaintiff Deadline of August 18, 2023

PR Newswire July 14, 2023

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile July 13, 2023

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 13, 2023

NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire July 13, 2023

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NovoCure Limited - NVCR

PR Newswire July 12, 2023

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

Newsfile July 12, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile July 12, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 12, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NovoCure Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2023 - (NASDAQ: NVCR)

PR Newswire July 12, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

PR Newswire July 11, 2023

ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited with Losses Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

Newsfile July 11, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile July 11, 2023

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 11, 2023

NVCR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 18, 2023 in the Class Action Filed on Behalf of NovoCure Limited Shareholders

PR Newswire July 11, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile July 10, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 10, 2023

ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited with Losses Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

Newsfile July 9, 2023

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

PR Newswire July 8, 2023